P3 Health Partners Inc has a consensus price target of $4.5 based on the ratings of 4 analysts. The high is $4.5 issued by Lake Street on March 14, 2024. The low is $4.5 issued by Lake Street on March 14, 2024. The 2 most-recent analyst ratings were released by Lake Street and BTIG on March 14, 2024 and September 1, 2023, respectively. With an average price target of $4.75 between Lake Street and BTIG, there's an implied 630.77% upside for P3 Health Partners Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/01/2024 | Buy Now | — | BTIG | David Larsen | — | Downgrade | Buy → Neutral | Get Alert |
03/14/2024 | Buy Now | 592.31% | Lake Street | Brooks O'Neil | $9 → $4.5 | Maintains | Buy | Get Alert |
09/01/2023 | Buy Now | 669.23% | BTIG | David Larsen | → $5 | Initiates | → Buy | Get Alert |
06/30/2023 | Buy Now | — | TD Cowen | Gary Taylor | — | Initiates | → Market Perform | Get Alert |
01/04/2022 | Buy Now | — | William Blair | Ryan Daniels | — | Initiates | → Outperform | Get Alert |
The latest price target for P3 Health Partners (NASDAQ:PIII) was reported by BTIG on April 1, 2024. The analyst firm set a price target for $0.00 expecting PIII to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
The latest analyst rating for P3 Health Partners (NASDAQ:PIII) was provided by BTIG, and P3 Health Partners downgraded their neutral rating.
There is no last upgrade for P3 Health Partners
The last downgrade for P3 Health Partners Inc happened on April 1, 2024 when BTIG changed their price target from N/A to N/A for P3 Health Partners Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of P3 Health Partners, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for P3 Health Partners was filed on April 1, 2024 so you should expect the next rating to be made available sometime around April 1, 2025.
While ratings are subjective and will change, the latest P3 Health Partners (PIII) rating was a downgraded with a price target of $0.00 to $0.00. The current price P3 Health Partners (PIII) is trading at is $0.65, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.